|
Name |
3-dimethylacetal-7β-hydroxygitoxigenin
|
| Molecular Formula | C25H38O8 | |
| IUPAC Name* |
3-(7,12,14,16-tetrahydroxy-3,3-dimethoxy-10,13-dimethyl-2,4,5,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2H-furan-5-one
|
|
| SMILES |
COC1(OC)CCC2(C)C(CC(O)C3C2CC(O)C2(C)C(C4=CC(=O)OC4)C(O)CC32O)C1
|
|
| InChI |
InChI=1S/C25H38O8/c1-22-5-6-24(31-3,32-4)10-14(22)8-16(26)21-15(22)9-18(28)23(2)20(13-7-19(29)33-12-13)17(27)11-25(21,23)30/h7,14-18,20-21,26-28,30H,5-6,8-12H2,1-4H3/t14-,15+,16+,17+,18-,20+,21+,22+,23-,25+/m1/s1
|
|
| InChIKey |
MJCMCGSETCCXFJ-KGMOVPSNSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 466.57 | ALogp: | 1.1 |
| HBD: | 4 | HBA: | 8 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 125.7 | Aromatic Rings: | 5 |
| Heavy Atoms: | 33 | QED Weighted: | 0.365 |
| Caco-2 Permeability: | -5.135 | MDCK Permeability: | 0.00018781 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.901 |
| Human Intestinal Absorption (HIA): | 0.826 | 20% Bioavailability (F20%): | 0.88 |
| 30% Bioavailability (F30%): | 0.446 |
| Blood-Brain-Barrier Penetration (BBB): | 0.772 | Plasma Protein Binding (PPB): | 43.04% |
| Volume Distribution (VD): | 3.119 | Fu: | 50.38% |
| CYP1A2-inhibitor: | 0.003 | CYP1A2-substrate: | 0.757 |
| CYP2C19-inhibitor: | 0.004 | CYP2C19-substrate: | 0.667 |
| CYP2C9-inhibitor: | 0.028 | CYP2C9-substrate: | 0.251 |
| CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.256 |
| CYP3A4-inhibitor: | 0.038 | CYP3A4-substrate: | 0.235 |
| Clearance (CL): | 10.167 | Half-life (T1/2): | 0.177 |
| hERG Blockers: | 0.032 | Human Hepatotoxicity (H-HT): | 0.336 |
| Drug-inuced Liver Injury (DILI): | 0.009 | AMES Toxicity: | 0.029 |
| Rat Oral Acute Toxicity: | 0.983 | Maximum Recommended Daily Dose: | 0.575 |
| Skin Sensitization: | 0.241 | Carcinogencity: | 0.075 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
| Respiratory Toxicity: | 0.192 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005142 | ![]() |
0.703 | D04RYU | ![]() |
0.382 | ||
| ENC005145 | ![]() |
0.604 | D0AR3J | ![]() |
0.374 | ||
| ENC005147 | ![]() |
0.604 | D02OZE | ![]() |
0.350 | ||
| ENC005140 | ![]() |
0.545 | D0M2QH | ![]() |
0.338 | ||
| ENC005146 | ![]() |
0.545 | D0L4SD | ![]() |
0.335 | ||
| ENC005144 | ![]() |
0.487 | D0M9QK | ![]() |
0.335 | ||
| ENC005141 | ![]() |
0.436 | D0M3QP | ![]() |
0.324 | ||
| ENC001476 | ![]() |
0.350 | D0V3GA | ![]() |
0.311 | ||
| ENC001007 | ![]() |
0.310 | D0OR2L | ![]() |
0.310 | ||
| ENC002216 | ![]() |
0.307 | D07TGN | ![]() |
0.300 | ||